Results 171 to 180 of about 27,057 (223)

Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis. [PDF]

Cancers (Basel)
Campanelli R, Carolei A, Catarsi P, Abbà C, Boveri E, Paulli M, Gentile R, Morosini M, Albertini R, Mantovani S, Massa M, Barosi G, Rosti V.   +12 more
europepmc   +1 more source

Advances in Molecular Understanding of Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis: Towards Precision Medicine. [PDF]

Cancers (Basel)
Tashkandi H, Younes IE.
europepmc   +1 more source

Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis. [PDF]

Am J Hematol
Abbonante V, Karkempetzaki AI, Leon C, Krishnan A, Huang N, Di Buduo CA, Cattaneo D, Ward CM, Matsuura S, Guinard I, Weber J, De Acutis A, Vozzi G, Iurlo A, Ravid K, Balduini A.   +15 more
europepmc   +1 more source

Ruxolitinib associated psoas muscle tuberculosis abscess in a primary myelofibrosis woman: A case report and literature review. [PDF]

Medicine (Baltimore)
Chen CY, Chen TC.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Primary myelofibrosis

2010
Myelofibrosis is a reactive process common to many malignant and benign disorders. Primary myelofibrosis is a chronic myeloproliferative disorder of unknown aetiology that involves a multipotent haemopoietic progenitor cell and results in abnormalities in red cell, white cell, and platelet production in association with marrow fibrosis and ...
Yuranga Weerakkody, Rohit Sharma, Evangeline Collins   +2 more
openaire   +2 more sources

Prognostication in Primary Myelofibrosis

Current Hematologic Malignancy Reports, 2011
Primary myelofibrosis (PMF) is a Philadelphia chromosome-negative chronic myeloproliferative neoplasm usually affecting elderly people. Median survival currently approaches 6 years, with a few patients surviving more than 20 years but others dying soon after diagnosis. In 10% to 20% of patients, PMF evolves into acute leukemia.
Francisco, Cervantes, Arturo, Pereira
openaire   +2 more sources

Primary hypertrophic osteoarthropathy with myelofibrosis

Rheumatology International, 2007
Primary hypertrophic osteoarthropathy or pachydermoperiostosis is a rare congenital disease characterized by clubbing of the fingers, periostitis of the distal long bones, and hypertrophic skin changes (pachydermia) including thick folds in the skin of the face, forehead, scalp and extremities, and also joint pain.
Massoud, Saghafi, Azita, Azarian, Najmeh, Nohesara   +2 more
openaire   +2 more sources

Renal complications of primary myelofibrosis

Leukemia & Lymphoma, 2018
Primary myelofibrosis (PMF) is a disease of the elderly, with a median age at diagnosis of 71 years.
Paolo, Strati, William F, Glass, Maen, Abdelrahim, Umut, Selamet, Amanda, Tchakarov, Biruh T, Workeneh, Srdan, Verstovsek, Ala, Abudayyeh   +7 more
openaire   +2 more sources

OCULAR MANIFESTATIONS OF PRIMARY MYELOFIBROSIS

RETINAL Cases & Brief Reports, 2016
Purpose: To report ocular manifestations of idiopathic primary myelofibrosis in a patient with relapsed primary myelofibrosis. Methods: Observational case report. Results: A 57-year-old African American male with history of primary ...
Albert L, Lin, Jordan M, Burnham, Victor, Pang, Omolola, Idowu, Siva, Iyer   +4 more
openaire   +2 more sources